Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rabies G protein vaccine - CPL Biologicals

Next Previous
X
Search
Drug Profile

Rabies G protein vaccine - CPL Biologicals

Alternative Names: Rabies G protein nanoparticle vaccine - CPL Biologicals; Recombinant nanoparticle rabies vaccine - CPL Biologicals; VLP-based rabies G protein vaccine - CPL Biologicals

Latest Information Update: 28 Sep 2020

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novavax
  • Developer CPL Biologicals
  • Class Protein vaccines; Recombinant proteins; Synthetic vaccines; Viral vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Rabies

Most Recent Events

  • 28 Sep 2020 Phase III clinical trials in Rabies ongoing in India (IM) (CTRI/2016/08/007137)
  • 02 Aug 2016 Cadila Pharmaceuticals plans a phase III trial for Rabies in India (IM) (CTRI/2016/08/007137)
  • 10 Mar 2014 Cadila Pharmaceuticals completes enrolment in a phase I/II trial in Rabies in India (CTRI/2014/04/004538)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top